Callan Capital, LLC Connect Biopharma Holdings LTD Transaction History
Callan Capital, LLC
- $1.42 Billion
- Q3 2024
A detailed history of Callan Capital, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Callan Capital, LLC holds 41,823 shares of CNTB stock, worth $40,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,823Holding current value
$40,986% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTB
# of Institutions
12Shares Held
3.05MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$2.05 Million1.77% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$500,4860.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny176KShares$171,9900.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$101,8130.0% of portfolio
-
Keudell33.5KShares$32,7810.01% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $53.9M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...